Rounds and Seminars

Neurology Grand Rounds

"Neurology Resident Research Grand Rounds"


Event date: 6/3/2025 8:00 AM - 9:00 AM iCal Export

Location: Samis Education Center

Room: 3rd Floor Conference Room


Topic: "Neurology Resident Research Grand Rounds"

Speakers: Christian H. Loveland, M.D., Zain Y. Khan, M.D., Evan S. Fields, M.D., Estevao P. Ribeiro, M.D., Mariano C. Brandao, M.D.

Speaker Disclosures: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speakers and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable. Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.


Learning Objectives:

Headaches are SMART: Stroke-like Migraine Attacks after Radiation Therapy Syndrome
Christian H. Loveland, M.D.

  1. Name which patient populations get SMART syndrome.
  2. Integrate SMART syndrome in a wide neurological differential diagnosis.

Effectiveness of Standardized EEG Curriculum in Improving the Proficiency of EEG Interpretation by Neurology Residents
Zain Y. Khan, M.D.

  1. Briefly review the limitations of EEG training during residency and previous studies which have tried to address concerns.
  2. Discuss the study design for evaluating the effectiveness of standardized EEG curriculum improving proficiency of EEG interpretation by neurology residents.

Hypertonic Saline in Acute MCA-territory Infarction (SAMI)
Evan S. Fields, M.D.

  1. Define malignant middle cerebral artery (MCA) stroke.
  2. Review current medical and surgical management of malignant MCA stroke.
  3. Relate the basis for current guidelines for the use of osmotic therapy in ischemic stroke.

Acetazolamide Exposure Association with Decreased Risk for Alzheimer’s Disease (AD)
Estevao P. Ribeiro, M.D.

  1. Outline current evidence associating acetazolamide exposure with decreased risk for AD, and the different mechanisms of action postulated.
  2. Describe current project’s framework and proposal.

Spectrum of Clinical and Paraclinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
Mariano C. Brandao, M.D.

  1. Identify the profile of clinical, radiological and laboratory data at disease onset of adult case series of MOGAD at OUHSC.
  2. Characterize the outcome, risk of relapse, clinical profile of relapse and type of acute and disease modifying therapy.


CE Credits: 1

For More Information Contact:

Brigitte Nettles
Department of Neurology
T 405-271-4113 X46023
F 405-271-5723
brigitte-nettles@ouhsc.edu

If you wish to view this GR later or past GR, go to:
https://mediasite.ouhsc.edu/Mediasite/Channel/neurogr